We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking INTI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
IN

Inhibitor Therapeutics, Inc. (INTI) short interest & options flow

OTCPK

Inhibitor Therapeutics heads into the final days of April with a quietly unusual setup: short interest has collapsed to near-zero, yet the cost to borrow has more than doubled over the past year — a combination that tells its own story about a thinly traded OTC biotech. The dominant move over the past month has been a sharp retreat from short sellers. Estimated short interest fell…

$0.08+1.27% 1d+1.27% 1w-18.37% 1mClose: 10 Nov 2026
Short interest % of float
Low and dropping
Live SI on ORTEX →
Cost to borrow
Rising
Live CTB on ORTEX →
Availability
High
Live availability on ORTEX →
Market cap
$14M
Next earnings
17 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of Inhibitor Therapeutics, Inc. (INTI) share price and short interest (% of free float), six months to November 10, 2026

INTI news and analysis

RSS

No long-form analysis yet for INTI. Pulse alerts and the live data picture are available on ORTEX.

Open INTI on ORTEX →

Want the live picture for INTI?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INTI — free to start on ORTEX.

Sign up for free →Open INTI on ORTEX